Hledáme partnery pro společný vývoj léčiv bakteriálních infekcí

Britská společnost vyvíjí léčbu nemocí způsobených bakteriemi, obzvláště pak bakteriemi rezistivními vůči antibiotikům. Metody využívá bakteriofágy (fágy), které působí pouze na cílové bakterie jsou zcela neškodné a bezpečné pro savce. tyto fágy ničí cílové bakterie bez ohledu na jejich odolnost vůči antibiotikům.
Tato společnost hledá partnery pro další společný vývoj léčiv požadovaných nemocí (bakteriálních infekcí).

Description:
The complexity of the antibiotic resistance issue and the immense research and development costs and time frames for developing new antibiotics means that viable alternatives to traditional antibiotics are desperately needed.

A UK SME is looking to build collaborations that can overcome bacterial diseases where antibiotic resistance is a problem, using their phage therapy expertise. In particular the company is looking for partners to develop their technology by expanding the range of infections they can target.

Bacteriophages are viruses which only infect bacteria. They attach to receptors on the surface of bacteria, inject their genetic material through the bacterial membrane and kill the host while producing (often) hundreds of progeny phage. In the treatment developed by the company the phages infect and kill bacteria regardless of their susceptibility to antibiotics and could therefore be used in the fight against antibiotic resistant bacteria. The company is seeking partners with expertise in bacterial diseases to jointly develop new treatments for other specific bacterial infections.

The aim of the collaboration is to develop further treatments for antibiotic resistant bacteria using bacteriophages (or phages).
Technical Specifications / Specific technical requirements of the request
Phage therapy is a viable alternative to traditional antibiotics, which is currently undergoing clinical trials. Due to the biological nature of phage products, resistance is not an issue as this can easily be overcome by the use of new phages, either by selecting a new phage or isolation of the new phage from the environment.

The company is looking for organizations specializing in developing bacterial disease treatments to jointly develop new treatments for specific bacterial infections.

Comments:
Type of partner sought: Companies, Research Centres

Specific area of activity of the partner: Bacterial disease research organisations

Task to be performed by the partner sought: Joint further development of new treatments

(Ref: 12 GB 45P2 3QUB )

Inovace